$RNAC Income Statement | Understand Stock

$RNAC

$6.46 +$0.18 (2.87%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue:
Collaboration and license
Grant
Total revenues
Operating expenses:
Research and development
General and administrative
Impairment of long-lived assets
Impairment of indefinite-lived intangible and long-lived assets
Total operating expenses
Operating loss
Investment income
Loss on extinguishment of debt
Other income (expense):
Interest income
Foreign currency transaction, net
Interest expense
Gain on change in fair value of warrant liabilities
Loss on change in fair value of contingent value right liability
Loss on change in fair value of forward contract liabilities
Other (expense) income, net
Total other income (expense), net
Loss before income taxes
Income tax benefit (expense)
Net loss
Other comprehensive income (loss):
Foreign currency translation adjustment
Unrealized gain on marketable securities
Total comprehensive loss
Net loss per share allocable to common stockholders:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted-average common shares outstanding:
Basic (in shares)
Diluted (in shares)

Comments